•
Dec 31, 2024

ClearPoint Neuro Q4 2024 Earnings Report

Expected Revenue:$8.23M
+26.0% YoY
Expected EPS:-$0.16
+20.0% YoY

Key Takeaways

ClearPoint Neuro reported a 14% increase in revenue for the fourth quarter of 2024, reaching $7.8 million. The company's full-year revenue grew by 31% to $31.4 million. They also reduced operational cash burn by 35% for the year and fully repaid a $10 million convertible note, leaving them with no outstanding debt. The company activated six new global centers in the fourth quarter, with a total of 25 in 2024.

Q4 2024 revenue reached $7.8 million, a 14% increase year-over-year.

Full-year 2024 revenue was reported at $31.4 million, a 31% increase over 2023.

Six new global centers were activated in Q4 2024, totaling 25 new centers for the year.

The company fully repaid a $10 million convertible note, eliminating all outstanding debt.

Total Revenue
$7.77M
Previous year: $6.81M
+14.1%
Gross Profit
$4.76M
Previous year: $4.01M
+18.7%
Cash and Equivalents
$20.1M
Previous year: $23.1M
-13.1%
Free Cash Flow
-$1.51M
Previous year: -$1.19M
+26.6%
Total Assets
$39.2M
Previous year: $42.7M
-8.1%

ClearPoint Neuro

ClearPoint Neuro

ClearPoint Neuro Revenue by Segment

Forward Guidance

The Company estimates revenue in 2025 to be between $36.0 million and $41.0 million, representing growth between 15% and 31%.